SAP vs SNOA
SAP (SAP) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
SAP (SAP) common stock.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
SAP does not have a complete income-statement cache yet.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
SAP currently screens at market cap $0. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the SAP and SNOA stock pages for the full models.
Not investment advice.